Production of antibodies to staphylococcal superantigens in atopic dermatitis

Archives of Disease in Childhood

Volumn 79, Issue 5, 1998, Pages 400-404

  Campbell, D E ^a   Kemp, A S ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Antibody; Atopic dermatitis; Staphylococcus; Superantigen

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ADOLESCENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; ATOPIC DERMATITIS; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STAPHYLOCOCCUS; T LYMPHOCYTE ACTIVATION;

EID: 0031731835     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.79.5.400     Document Type: Article

References (27)

1. Kappler J, Kotzin B, Herron L, et al. V beta-specific stimulation of human T cells by staphylococcal toxins. Science 1989;244:811-13.
2. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1981;i:1017-21.
3. Evenson ML, Hinds MW, Bernstein RS, Bergdoll MS. Estimation of human dose of staphylococcal enterotoxin A from a large outbreak of staphylococcal food poisoning involving chocolate milk. Int J Food Microbiolol 1988;7:311-6.
4. Pereira JL, Salzberg SP, Bergdoll MS. Production of staphylococcal enterotoxin D in foods by low-enterotoxin-producing staphylococci. Int J Food Microbiol 1991;14:19-25.
5. Abe J, Kotzin BL, Jujo K, et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A 1992; 89:4066-70.
6. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-8.
7. Hoeger PH, Lenz W, Boutonnier A, Fournier JM. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992;165:1064-8.
8. Leung DY, Harbeck R, Bina P, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 1993;92:1374-80.
9. Rosten PM, Bartlett KH, Chow AW. Serologic responses to toxic shock syndrome (TSS) toxin-1 in menstrual and nonmenstrual TSS. Clin Invest Med 1988;11:187-92.
10. Jacobson JA, Kasworm E, Daly JA. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongonital staphylococcal infection. Rev Infect Dis 1989;11(suppl):S8-13.
11. Luber H, Amornsiripanitch S, Lucky AW. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis. Arch Dermatol 1988;124:853-4.
12. Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189-98.
13. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996;132:27-33.
14. Campbell DE, Kemp AS. Proliferation and production of interferon-gamma and IL-4 in response to Staphylococcus aureus and Staphylococcal superantigen in childhood atopic dermatitis. Clin Exp Immunol 1997;107:392-7.
15. Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 1995;154:6174-81.
16. Konig B, Neuber K, Konig W. Responsiveness of peripheral blood mononuclear cells from normal and atopic donors to microbial superantigens. Int Arch Allergy Immunol 1995; 106:124-33.
17. Reiser RF, Jacobson JA, Kasworm EM, Bergdoll MS. Staphylococcal enterotoxin antibodies in pediatric patients from Utah. J Infect Dis 1988;158:1105-8.
18. Christensson B, Hedstrom SA. Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls. Acta Pathol Microbiol Immunol Scand 1985;93:87-90.
19. Hanifin J, Rajika G. Diagnistic features of atopic dermatitis. Acta Derm Venered 1980;92(suppl):44-7.
20. Wilson C, Lewis D, Penix L. The physiologic immunodeficiency of immaturity. In: Stiehm E, ed. Immunological disorders in infants and children. Philadelphia: Saunders, 1996;265-8.
21. Loch EG, Crass BA, Bergdoll MS. Staphylococcus aureus toxic shock syndrome toxin-1 antibody titers in serum of German women. Arch Gynecol 1986;237:229-33.
22. Solino NA, da Costa CE, Bergdoll MS. Antibodies to staphylococcal enterotoxins and toxic shock syndrome toxin 1 in sera of patients and healthy people in Rio de Janeiro, Brazil. J Clin Microbiol 1986;24:809-11.
23. Schroder E, Kunstmann G, Hasbach H, Pulverer G. Prevalence of serum antibodies to toxic-shock-syndrome-toxin-1 and to staphylococcal enterotoxins A, B and C in West-Germany. Zentralbl Bakteriol Mikrobiol Hyg [A] 1988; 270:110-14.
24. Jacobson JA, Kasworm EM, Crass BA, Bergdoll MS, Nasal carriage of toxigenic Staphylococcus aureus and prevalence of serum antibody to toxic-shock-syndrome toxin 1 in Utah. J Infect Dis 1986;153:356-9.
25. Jacobson J, Kasworm E, Bolte R, HM C. Prevelence of nasal carriage of toxigenic staphylococcus and antibody to toxic shock syndrome toxin-1 in Utah children. Rev Infect Dis 1989;II:324-5.
26. Terai M, Miwa K, Williams T, et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 1995;172:558-61.
27. Betts Carpenter A. Enzyme linked immunoassays. In: Rose NR, ed. Manual of clinical and Liboratory immunology. Washington DC: American Society for Microbiology, 1992:2-9.